Porcine Epidemic Diarrhea Vaccines Market Growth Potential: What The Latest Forecast Reveals

Porcine Epidemic Diarrhea Vaccines Market Report

Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

Porcine Epidemic Diarrhea Vaccines Market Forecast: What Value Will The Market Reach By 2030?

The porcine epidemic diarrhea vaccines market has experienced substantial growth in recent years. It is projected to increase from $1.8 billion in 2025 to $1.94 billion in 2026, reflecting a compound annual growth rate (CAGR) of 7.6%. The expansion observed in prior periods can be attributed to various factors, including recurring outbreaks of porcine epidemic diarrhea, high mortality rates among neonatal piglets, economic losses incurred by the swine industry, the limited efficacy of non-vaccine disease control measures, and an enhanced reliance on veterinary-led disease prevention strategies.

The porcine epidemic diarrhea vaccines market is projected to experience robust expansion in the coming years. By 2030, this market is anticipated to reach a valuation of $2.5 billion, growing at a compound annual growth rate (CAGR) of 6.7%. Several factors are expected to fuel this growth during the forecast period, including the proliferation of intensive pig farming practices, an increasing worldwide appetite for pork products, greater understanding of the advantages of herd immunity, the expansion of structured hog production facilities, and supportive government programs for animal health. Key trends shaping the market over the forecast period encompass a wider embrace of preventive vaccination within swine health management, a developing preference for live vaccines in areas where the disease is prevalent, an escalating focus on immunizing piglets early, the expansion of vaccination initiatives in commercial hog operations, and an enhanced focus on biosecurity and disease control measures.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=55004263&type=smp&name=Porcine%20Epidemic%20Diarrhea%20Vaccines%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Porcine Epidemic Diarrhea Vaccines Market Growth Backed By Core Demand Fundamentals

The anticipated expansion of pig farming is set to drive the future growth of the porcine epidemic diarrhea vaccine market. This practice encompasses the raising of domestic pigs for various purposes, including meat production, breeding, rearing, comprehensive management of animals from birth until they reach market weight, and the subsequent production and sale of pork products. This increase in pig farming is fueled by factors such as the rising global appetite for pork, progress in breeding and herd management techniques, enhancements in swine production technologies, and the widening reach of commercial pork markets. Within pig farming, porcine epidemic diarrhea (PED) vaccines are vital, contributing to the prevention and control of disease outbreaks, commonly administered during the gestation of sows to confer passive immunity to their newborn piglets. As an illustration, the U.S. Department of Agriculture, a US-based government agency, forecasted in April 2024 that U.S. pork production would hit 12.7 million metric tons, indicating a rise in swine output and reinforcing the ongoing growth of the pig farming industry. Consequently, the expansion of pig farming is a key driver for the growth of the porcine epidemic diarrhea vaccine market.

Porcine Epidemic Diarrhea Vaccines Market Segment Analysis Spotlighting Growth Areas

The porcine epidemic diarrhea vaccines market covered in this report is segmented –

1) By Product: Live Vaccines, Killed Vaccines

2) By Application: Piglets, Adults Pigs

3) By End-User: Veterinary Hospitals, Hog Production Farms

Subsegments:

1) By Live Vaccines: Oral Live Vaccines, Injectable Live Vaccines

2) By Killed Vaccines: Inactivated Injectable Vaccines, Inactivated Oral Vaccines

Porcine Epidemic Diarrhea Vaccines Market Growth Trends Reshaping The Competitive Landscape

Leading companies in the Porcine Epidemic Diarrhea (PED) vaccines market are focusing on developing innovative solutions, such as next-generation inactivated and recombinant vaccines, to improve immunity and offer broader protection against emerging PEDV strains. These advanced next-generation inactivated and recombinant vaccines employ either killed viruses or engineered viral proteins to stimulate strong, targeted immunity while enhancing safety and defense against evolving disease strains. For example, in August 2024, Zoetis Inc., a US-based animal health company, secured a grant for Porcine Epidemic Diarrhea Virus (PEDV) vaccine research and was also granted a conditional license by the U.S. Department of Agriculture (USDA) for a PEDV vaccine for pigs. These actions solidify Zoetis’s position in developing advanced swine health solutions by supporting further research, boosting vaccine effectiveness, and extending protection against new PEDV strains.

Porcine Epidemic Diarrhea Vaccines Market Leading Companies: Who Holds The Strongest Market Presence?

Major companies operating in the porcine epidemic diarrhea vaccines market are Zoetis Inc., Merck Animal Health, MSD Animal Health, Elanco Animal Health, Boehringer Ingelheim Animal Health, Ceva Santé Animale, Phibro Animal Health Corporation, IDT Biologika GmbH, Vaxxinova, Qilu Animal Health Products Factory Co. Ltd., Green Cross Veterinary Products Co. Ltd., Nisseiken Co. Ltd., Ourofino Saúde Animal, Medgene Labs, Harrisvaccines Inc., Tecnovax, Komipharm International Co. Ltd., Bioveta a.s., HIPRA, CZ Vaccines

View The Full Porcine Epidemic Diarrhea Vaccines Market Report:

https://thebusinessresearchcompany.com/report/porcine-epidemic-diarrhea-vaccines-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Porcine Epidemic Diarrhea Vaccines Market Geographic Analysis: Where Is Demand Accelerating Fastest?

Asia-Pacific was the largest region in the porcine epidemic diarrhea vaccines market in 2025. The regions covered in the porcine epidemic diarrhea vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model